Motoaki Saito Selected Research

Ischemia

7/2021	Protective Role of Glutathione in the Hippocampus after Brain Ischemia.
1/2021	[The neuroprotective role of EAAC1 in hippocampal injury following ischemia-reperfusion].
1/2021	The role of diurnal fluctuations in excitatory amino acid carrier 1 levels in post-ischemic hippocampal Zn2+ accumulation.
12/2018	Attenuation of zinc-enhanced inflammatory M1 phenotype of microglia by peridinin protects against short-term spatial-memory impairment following cerebral ischemia in mice.
6/2012	Nicorandil ameliorates hypertension-related bladder dysfunction in the rat.
5/2012	The role of K ATP channels on ischemia-reperfusion injury in the rat testis.
10/2009	Ischemic preconditioning and post-conditioning to decrease testicular torsion-detorsion injury.
4/2008	Neutrophil elastase inhibitor, sivelestat sodium hydrate prevents ischemia-reperfusion injury in the rat bladder.
7/2007	Beneficial effect of preconditioning on ischemia-reperfusion injury in the rat bladder in vivo.
6/2006	Real-time monitoring of nitric oxide and blood flow during ischemia-reperfusion in the rat testis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Motoaki Saito Research Topics

Disease

13	Hypertension (High Blood Pressure) 05/2022 - 05/2011
13	Neoplasms (Cancer) 01/2022 - 01/2012
13	Ischemia 07/2021 - 01/2002
11	Body Weight (Weight, Body) 10/2021 - 09/2005
10	Reperfusion Injury 01/2016 - 01/2002
8	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2022 - 10/2010
8	Overactive Urinary Bladder (Overactive Bladder) 01/2022 - 08/2004
4	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 06/2007
4	Adenocarcinoma 01/2019 - 06/2007
4	Lower Urinary Tract Symptoms 09/2016 - 10/2010
4	Cystitis 09/2016 - 10/2009
4	Renal Cell Carcinoma (Grawitz Tumor) 11/2013 - 01/2012
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2021
3	Nocturia 01/2022 - 08/2005
3	Brain Ischemia (Cerebral Ischemia) 07/2021 - 12/2018
3	Ovarian Epithelial Carcinoma 02/2020 - 09/2014
3	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/2019 - 10/2004
3	Carcinoma (Carcinomatosis) 03/2018 - 11/2013
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2017 - 06/2014
3	Clear Cell Adenocarcinoma 12/2012 - 06/2007
3	Type 2 Diabetes Mellitus (MODY) 11/2012 - 08/2010
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2012 - 07/2008
3	Urinary Retention 09/2012 - 09/2009
3	Hypertrophy 02/2006 - 09/2005
2	Venous Thromboembolism 01/2022 - 09/2015
2	Pulmonary Embolism 01/2022 - 09/2015
2	Hyperemia 12/2019 - 01/2019
2	Endometrial Neoplasms (Endometrial Cancer) 06/2019 - 12/2017
2	Urinary Tract Infections (Urinary Tract Infection) 04/2019 - 12/2007
2	Neurogenic Urinary Bladder (Bladder, Neurogenic) 04/2019 - 12/2007
2	Infertility (Sterility) 11/2017 - 01/2016
2	Necrosis 01/2017 - 10/2009
2	Hypoxia (Hypoxemia) 01/2016 - 01/2014
2	Diabetic Nephropathies (Diabetic Nephropathy) 08/2008 - 08/2006
1	Pulmonary Hypertension 02/2022

Drug/Important Bio-Agent (IBA)

7	Interleukin-6 (Interleukin 6)IBA 02/2021 - 10/2013
7	Fatty AlcoholsIBA 01/2019 - 11/2002
6	1-hexacosanolIBA 08/2008 - 01/2006
5	silodosin FDA Link 03/2020 - 07/2012
5	Proteins (Proteins, Gene)FDA Link 12/2017 - 03/2004
5	rho-Associated KinasesIBA 11/2015 - 10/2009
5	EdaravoneIBA 10/2014 - 09/2009
5	Insulin (Novolin)FDA Link 06/2009 - 09/2005
5	Glucose (Dextrose)FDA LinkGeneric 06/2009 - 09/2005
4	Tadalafil (Cialis)FDA Link 01/2022 - 01/2019
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 10/2009
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 06/2007
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 10/2012
4	Cholinergic Antagonists (Anticholinergics)IBA 04/2019 - 08/2004
4	oxybutynin (Tavor)FDA LinkGeneric 04/2019 - 08/2004
4	hydroxyfasudilIBA 11/2015 - 10/2009
4	Nicorandil (SG 75)IBA 01/2015 - 05/2011
4	Free Radical ScavengersIBA 10/2014 - 09/2009
4	Adenosine Triphosphate (ATP)IBA 09/2012 - 06/2010
4	salicylhydroxamic acid (SHAM)IBA 10/2009 - 10/2004
3	Pharmaceutical PreparationsIBA 05/2022 - 08/2005
3	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 06/2019
3	Messenger RNA (mRNA)IBA 01/2022 - 10/2009
3	ZincIBA 07/2021 - 12/2018
3	PlatinumIBA 06/2019 - 07/2007
3	Cisplatin (Platino)FDA LinkGeneric 06/2019 - 07/2007
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2012
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2018 - 06/2006
3	Arginine (L-Arginine)FDA Link 10/2018 - 01/2002
3	Nitric Oxide Synthase (NO Synthase)IBA 10/2018 - 01/2002
3	NG-Nitroarginine Methyl Ester (L-NAME)IBA 05/2011 - 01/2002
2	Losartan (Cozaar)FDA LinkGeneric 05/2022 - 02/2021
2	Peroxidase (Myeloperoxidase)IBA 01/2022 - 10/2009
2	Therapeutic UsesIBA 02/2021 - 01/2019
2	taxaneIBA 06/2019 - 12/2011
2	CytokinesIBA 12/2018 - 01/2016
2	Capsaicin (Zostrix)FDA Link 01/2018 - 09/2016
2	AntioxidantsIBA 11/2017 - 10/2012
2	naftopidilIBA 09/2016 - 04/2013
2	olmesartanIBA 03/2014 - 01/2014
2	Hemoglobins (Hemoglobin)IBA 01/2014 - 10/2013
2	Fas Ligand Protein (Fas Ligand)IBA 10/2013 - 01/2012
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2012 - 07/2007
2	KATP ChannelsIBA 09/2012 - 06/2010
2	PotassiumIBA 09/2012 - 05/2011
2	sivelestatIBA 01/2011 - 04/2008
2	Secretory Proteinase Inhibitory ProteinsIBA 01/2011 - 04/2008
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 10/2010 - 11/2004
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 10/2009 - 03/2004
2	Streptozocin (Streptozotocin)FDA Link 08/2008 - 08/2006
2	loxoprofen (CS 600)IBA 08/2005 - 02/2005
1	levodopa receptorIBA 02/2022
1	MonocrotalineIBA 02/2022
1	ferrous citrate FDA Link 01/2022
1	ImmunosorbentsIBA 01/2022
1	Heme (Haem)IBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022

Therapy/Procedure

7	Therapeutics 01/2022 - 08/2004
6	Drug Therapy (Chemotherapy) 02/2020 - 08/2005
4	Nephrectomy 11/2013 - 01/2012
4	Surgical Instruments (Clip) 09/2009 - 08/2004
2	Adjuvant Chemotherapy 08/2021 - 06/2019
2	Ischemic Postconditioning 01/2016 - 10/2009
2	Neoadjuvant Therapy 01/2016 - 01/2014
1	Radiotherapy 01/2022